When the former US President <a href="https://www.wionews.com/topics/donald-trump">Donald Trump</a> got infected by the deadly coronavirus, he claimed to have tried experimental antibodies, which reportedly worked as a magical cure against the virus.

While the world made fun of his claims, some thought it might be possible. Now, Germany has become the first European Union country to order the same drugs.

Also read|&nbsp;<a href="https://www.wionews.com/world/watch-melania-trump-refuses-to-pose-with-donald-trump-after-he-leaves-white-house-twitter-laughs-358514">Watch: Melania Trump refuses to pose with Donald Trump after he leaves White House; Twitter laughs</a>

"The government has bought 200,000 doses for 400 million euros ($486 million)," German health minister Jens Spahn told a local newspaper.

As of now, it is not known who is the manufacturer of these drugs, but it has been confirmed by the German health ministry that these drugs are the same ones which were given to Trump during his ill period in October.

Spahn has claimed these drugs can help avoid any serious progression of the virus in highly-vulnerable or high-risk patients.

Also read|&nbsp;<a href="https://www.wionews.com/opinions-blogs/the-end-of-trump-can-be-the-beginning-of-america-358889" hreflang="en">The end of Trump can be the beginning of America</a>

"They work like a passive vaccination. Administering these antibodies in the early stages can help high-risk patients avoid a more serious progression," he said.

Trump was given the experimental-antibody treatment which was then developed by a US firm Regeneron, known as REGN-COV2. He had chosen to take this treatment even before it had been approved by the regulators.

However, Trump was massively pleased with the medicine and had claimed it to be a magic cure against coronavirus which had done "a fantastic job".

Also read|&nbsp;<a href="https://www.wionews.com/world/trump-impeachment-trial-put-off-until-early-february-358797" hreflang="en">Trump impeachment trial put off until early February</a>

This treatment is considered to be a cocktail of two antibodies which are prepared in laboratories and contain infection-fighting proteins that were developed to bind to the part of the new coronavirus that it uses to invade human cells.

The antibodies attach themselves to different parts of the virus's spike protein, distorting its structure -- similar in a way to knocking a key out of shape so it no longer fits its lock.

Order of these antibodies by Germany has come after the country has already started a mass vaccination drive for the Pfizer-BioNTech and AstraZeneca.&nbsp;

However, after Pfizer-BioNTech declared a possible delay in delivery of vials of vaccine, several European governments have been looking at other alternates of the vaccine for the meantime.

When the former US President Donald Trump got infected by the deadly coronavirus, he claimed to have tried experimental antibodies, which reportedly worked as a magical cure against the virus.

When the former US President Donald Trump got infected by the deadly coronavirus, he claimed to have tried experimental antibodies, which reportedly worked as a magical cure against the virus. While the world made fun of his claims, some thought it might be possible. Now, Germany has become the first European Union country to order the same drugs. Also read| Watch: Melania Trump refuses to pose with Donald Trump after he leaves White House; Twitter laughs "The government has bought 200,000 doses for 400 million euros ($486 million)," German health minister Jens Spahn told a local newspaper. As of now, it is not known who is the manufacturer of these drugs, but it has been confirmed by the German health ministry that these drugs are the same ones which were given to Trump during his ill period in October. Spahn has claimed these drugs can help avoid any serious progression of the virus in highly-vulnerable or high-risk patients. Also read| The end of Trump can be the beginning of America "They work like a passive vaccination. Administering these antibodies in the early stages can help high-risk patients avoid a more serious progression," he said. Trump was given the experimental-antibody treatment which was then developed by a US firm Regeneron, known as REGN-COV2. He had chosen to take this treatment even before it had been approved by the regulators. However, Trump was massively pleased with the medicine and had claimed it to be a magic cure against coronavirus which had done "a fantastic job". Also read| Trump impeachment trial put off until early February This treatment is considered to be a cocktail of two antibodies which are prepared in laboratories and contain infection-fighting proteins that were developed to bind to the part of the new coronavirus that it uses to invade human cells. The antibodies attach themselves to different parts of the virus's spike protein, distorting its structure -- similar in a way to knocking a key out of shape so it no longer fits its lock. Order of these antibodies by Germany has come after the country has already started a mass vaccination drive for the Pfizer-BioNTech and AstraZeneca. However, after Pfizer-BioNTech declared a possible delay in delivery of vials of vaccine, several European governments have been looking at other alternates of the vaccine for the meantime.

Germany orders coronavirus drugs that cured Donald Trump

Nearly two-thirds of multi-drug antibiotic cocktails sold in India between 2007 and 2012 were unapproved, said researchers Monday, warning such &quot;illegal&quot; compounds were fuelling the spread of drug-resistant diseases.

In total, 118 different types of &quot;fixed-dose combination&quot; antibiotics -- formulations combining two or more drugs in a single pill -- were sold in India in the five years under review, a team reported in the British Journal of Clinical Pharmacology.

Of these, &quot;64 percent were not approved by the national drugs regulator, the Central Drugs Standard Control Organisation&quot;, they said.

The sale of unapproved drugs is illegal in India.

The 118 formulations were sold as 3,307 different brand-named products, produced by 476 pharmaceutical companies -- including a dozen multinationals, said the team.

There were also 86 single-drug formulations, of which 93 percent had regulatory approval.

&quot;Selling unapproved, unscrutinised antibiotics undermines measures in India to control antimicrobial resistance,&quot; said the study&#39;s lead author Patricia McGettigan of the Queen Mary University in London.

&quot;Multinational companies should explain the sale of products in India that did not have the approval of their own national regulators and, in many cases, did not even have the approval of the Indian regulator,&quot; she said in a statement.

India already has one of the highest rates of drug resistance in the world, said the team, coupled with one of the highest antibiotic consumption rates.

The UN warns that the emergence of drug-resistant germs is a &quot;global health emergency&quot; threatening progress made by modern medicine, and risking a future in which people die of ailments that are easily curable today.

A report commissioned by the British government warned in 2014 that antibiotics-resistant infections could kill 10 million people per year globally by 2050, making it the leading cause of death over heart disease and cancer.&nbsp;

Bacteria acquire drug resistance partly through exposure to antibiotics.&nbsp;

Instead of killing the germs, the wrong type of antibiotic or the wrong dose can stimulate the bugs to fight back -- either by spontaneous DNA mutations that confer immunity, or by transferring resistant genes between themselves.

This can also happen when humans are exposed to antibiotics in animals they consume, or in the water or soil they come into contact with.

The study appeared in the British Journal of Clinical Pharmacology

Nearly two-thirds of multi-drug antibiotic cocktails sold in India between 2007 and 2012 were unapproved, said researchers Monday, warning such "illegal" compounds were fuelling the spread of drug-resistant diseases. In total, 118 different types of "fixed-dose combination" antibiotics -- formulations combining two or more drugs in a single pill -- were sold in India in the five years under review, a team reported in the British Journal of Clinical Pharmacology. Of these, "64 percent were not approved by the national drugs regulator, the Central Drugs Standard Control Organisation", they said. The sale of unapproved drugs is illegal in India. The 118 formulations were sold as 3,307 different brand-named products, produced by 476 pharmaceutical companies -- including a dozen multinationals, said the team. There were also 86 single-drug formulations, of which 93 percent had regulatory approval. "Selling unapproved, unscrutinised antibiotics undermines measures in India to control antimicrobial resistance," said the study's lead author Patricia McGettigan of the Queen Mary University in London. "Multinational companies should explain the sale of products in India that did not have the approval of their own national regulators and, in many cases, did not even have the approval of the Indian regulator," she said in a statement. India already has one of the highest rates of drug resistance in the world, said the team, coupled with one of the highest antibiotic consumption rates. The UN warns that the emergence of drug-resistant germs is a "global health emergency" threatening progress made by modern medicine, and risking a future in which people die of ailments that are easily curable today. A report commissioned by the British government warned in 2014 that antibiotics-resistant infections could kill 10 million people per year globally by 2050, making it the leading cause of death over heart disease and cancer. Bacteria acquire drug resistance partly through exposure to antibiotics. Instead of killing the germs, the wrong type of antibiotic or the wrong dose can stimulate the bugs to fight back -- either by spontaneous DNA mutations that confer immunity, or by transferring resistant genes between themselves. This can also happen when humans are exposed to antibiotics in animals they consume, or in the water or soil they come into contact with.

64% of antibiotic cocktails sold in India 'illegal': Study

cocktail-antibiotic

Cocktail Antibiotic, News on Cocktail Antibiotic, stories on Cocktail Antibiotic, articles on Cocktail Antibiotic, Cocktail Antibiotic stories at Wion, Cocktail Antibiotic news, Cocktail Antibiotic latest news

cocktail antibiotic

Germany orders coronavirus drugs that cured Donald Trump

64% of antibiotic cocktails sold in India 'illegal': Study